New Biologic Treatment for Male and Female Pattern Baldness
Part of Skin clinical trials.
This study tests a new experimental biologic treatment, XVIE, for male and female pattern baldness. It aims to see if the treatment is safe and can help regrow hair in people with mild to moderate thinning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have male or female pattern baldness that has been slowly getting worse for at least 6 months.
- You have not used certain hair loss treatments like minoxidil (Rogaine), finasteride (Propecia), or PRP injections in the past 3 to 6 months.
- You are generally healthy, with no uncontrolled thyroid problems, diabetes, autoimmune diseases, or bleeding disorders.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use birth control if needed.
- You have not had a hair transplant in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injections of exosomes (tiny particles from cells) can help regrow hair in men with mild to moderate male pattern baldness. It may offer a new treatment option without surgery.
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
This trial tests a cosmetic anti-hair loss product in men with early to moderate male pattern baldness. It looks at how well the product works and if it can help slow or reduce hair loss.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
This trial tests whether a new gel called Xvie, delivered into the scalp with tiny needles (microneedling), can help women who feel their hair is thinning. You will get the treatment in a clinic, and the study will see if it makes your hair look fuller.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.